Metabolomics Workbench : NIH Data Repository

Analysis	Metabolite Name	Measured Value	Units	Sample type	Gender
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	5429	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	6272	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	7297	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	8114	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	8630	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	9318	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10071	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10120	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10486	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10608	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10683	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10730	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	10940	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11113	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11281	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11294	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11308	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11518	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11564	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11683	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	11906	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12347	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12495	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12653	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12682	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12709	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12742	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12761	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12843	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	12867	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13075	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13211	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13250	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13258	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13695	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13695	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13722	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13770	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13777	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	13791	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14068	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14152	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14168	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14269	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14320	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14489	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14507	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14509	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14699	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14713	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14722	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	14875	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15164	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15446	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15602	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15725	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15896	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15898	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15953	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	15956	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16025	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16082	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16092	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16206	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16288	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16295	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16378	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16418	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16435	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16444	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16476	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16525	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16641	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16730	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16740	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16822	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	16947	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17005	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17042	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17145	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17512	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17702	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	17778	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18032	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18296	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18331	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18405	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18533	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18558	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18641	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18730	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18731	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18737	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18827	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18942	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18952	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	18969	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19060	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19158	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19212	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19491	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19656	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19837	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	19913	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20191	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20224	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20233	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20257	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20327	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20479	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20506	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20535	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20715	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	20740	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21070	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21250	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21512	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21535	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21600	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21617	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21635	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21641	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21755	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21803	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21831	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21883	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21890	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21903	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21917	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21959	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	21980	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22062	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22109	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22124	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22146	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22152	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22156	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22278	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22283	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22303	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22364	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22433	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22455	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22480	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22488	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22492	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22506	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22513	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22597	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22707	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22775	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22796	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22840	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22856	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	22948	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23013	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23044	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23075	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23140	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23242	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23244	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23307	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23322	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23372	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23379	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23390	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23394	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23491	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23558	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23621	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23631	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23779	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23835	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23846	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	23877	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24071	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24232	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24322	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24417	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24436	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24458	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24473	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24534	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24610	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24628	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24694	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24745	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24793	Peak area normalized	batch pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	24877	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25002	Peak area normalized	master pool	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25073	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25127	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25222	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25334	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25447	Peak area normalized	Sample	female
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25479	Peak area normalized	chear plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25481	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25491	Peak area normalized	red cross plasma	-
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25538	Peak area normalized	Sample	male
Reversed Phase NEGATIVE (Named metabolites)	phenyllactate	25544	Peak area normalized	Sample	female

Return to search page